GIVOSIRAN
givosiran 189 mg/mL injection, 1 mL vial
GIVOSIRAN (15289Q)
15289Q
Manner of administration:Injection
Restriction
Indication: Chronic treatment of Acute Hepatic Porphyria (AHP)
Treatment phase: Initial treatment
Restriction
Indication: Chronic treatment of Acute Hepatic Porphyria (AHP)
Treatment phase: Continuing treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 2 | Max qty units: 2 | # of repeats: 5 | DPMQ: $163,908.50 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Givlaari | |||||